Clinical Trial Update: PPAR - Combination With Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a PPAR-targeted therapy in combination with Metformin for diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED